EXACT Therapeutics

EXACT Therapeutics is a clinical-stage Norwegian biotechnology company dedicated to developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® sonoporation is a unique method of ultrasound-mediated targeted drug enhancement, with the potential to significantly amplify the clinical utility of various therapeutic agents across multiple indications, including oncology (chemotherapy, immunotherapy) and neurological disorders.